IMPORTANT SAFETY INFORMATION | 合法藥品大搜索
Thismightbeatyourdoctor'sofficeorwithavisitinghomenursefromViatrisAdvocatewhowillteachyouhowtogiveyourglatirameracetateinjections.
WhisperJECT and the Glatiramer Acetate Injection Logo are registered trademarks of Mylan Pharmaceuticals Inc., a Viatris Company.VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris Company.VIATRIS ADVOCATE and the Viatris Advocate Logo are registered trademarks of Mylan Inc., a Viatris Company.BD is a registered trademark of Becton, Dickinson and Company.COPAXONE is a registered trademark of Teva Pharmaceutical Industries Ltd.
© 2024 Viatris Inc. All Rights Reserved. GA-2022-0022 V5
Glatiramer Acetate (Professional Patient Advice) | 合法藥品大搜索
Copaxone (Glatiramer Acetate) Side effects | 合法藥品大搜索
Copaxone (Glatiramer Acetate): Uses | 合法藥品大搜索
Glatiramer Injection | 合法藥品大搜索
Injecting Viatris' Glatiramer Acetate Injection with ... | 合法藥品大搜索
IMPORTANT SAFETY INFORMATION | 合法藥品大搜索
Viatris Advocate Co | 合法藥品大搜索
Glatiramer Acetate | 合法藥品大搜索
Patient Information Leaflet Glatiramer Acetate Injection (gla ... | 合法藥品大搜索
GLATIRAMER ACETATE | 合法藥品大搜索
【貝他費隆 注射劑】降低反覆發作型多發性硬化症的發作頻率及嚴重度。降低續發型多發性硬化症(secondary progressive multiple sclerosis)復發的頻率及嚴重度。發生單一臨床症狀(Clinically Isolated Syndrome)疑似多發性硬化症的病患,可延緩其惡化成多發性硬化症。
藥品名稱:貝他費隆 注射劑許可證字號:衛署菌疫輸字第000601號許可證種類:菌 疫適應症:降低反覆發作型多發性硬化症的發作頻...
【柯珮鬆注射液20毫克】Copaxone用於治療首次出現臨床症狀且有MRI為佐證之多發性硬化症病人。復發型多發性硬化症Copaxone,用於減少復發型多發性硬化病人的復發頻率。
藥品名稱:柯珮鬆注射液20毫克許可證字號:衛部罕藥輸字第000033號許可證種類:製 劑適應症:Copaxone用於治療首次出現臨床症狀...
【柯珮鬆注射液40毫克】用於復發型多發性硬化症,以減少復發型多發性硬化症病人的復發頻率。
藥品名稱:柯珮鬆注射液40毫克許可證字號:衛部罕藥輸字第000035號許可證種類:製 劑適應症:用於復發型多發性硬化症,以減少復...